A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

Clinical trial NCT06849609 · RECRUITING

Trial details

NCT number: NCT06849609
Sponsor: Hong Chen
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2025-01-16
Primary completion: 2026-05-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.